BioDelivery Sciences International Company Profile (NASDAQ:BDSI)

About BioDelivery Sciences International

BioDelivery Sciences International logoBioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products aimed principally in the areas of pain management and addiction. The Company's products utilize the BioErodible MucoAdhesive (BEMA) drug delivery technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The Company's United Sates Food and Drug Administration (FDA) approved product, ONSOLIS (fentanyl buccal soluble film), as well as its approved products BUNAVAIL (buprenorphine and naloxone buccal film) buccal film and BELBUCA (buprenorphine) buccal film, utilize BEMA technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: BDSI
  • CUSIP: 09060J10
Key Metrics:
  • Previous Close: $1.90
  • 50 Day Moving Average: $1.90
  • 200 Day Moving Average: $2.16
  • 52-Week Range: $1.50 - $4.39
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.01
  • P/E Growth: -0.06
  • Market Cap: $108.78M
  • Outstanding Shares: 54,118,000
  • Beta: 1.02
Profitability:
  • Net Margins: -93.61%
  • Return on Equity: -309.49%
  • Return on Assets: -48.76%
Debt:
  • Debt-to-Equity Ratio: -3.47%
  • Current Ratio: 1.74%
  • Quick Ratio: 1.62%
Additional Links:
Companies Related to BioDelivery Sciences International:

Analyst Ratings

Consensus Ratings for BioDelivery Sciences International (NASDAQ:BDSI) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $5.50 (168.29% upside)

Analysts' Ratings History for BioDelivery Sciences International (NASDAQ:BDSI)
Show:
DateFirmActionRatingPrice TargetDetails
2/2/2017FBR & CoSet Price TargetBuy$5.00View Rating Details
1/17/2017Cantor FitzgeraldSet Price TargetHold$3.00View Rating Details
12/12/2016Roth CapitalSet Price TargetBuy$6.00View Rating Details
9/23/2016Janney Montgomery ScottUpgradeNeutral -> Buy$2.45 -> $4.00View Rating Details
8/10/2016Piper Jaffray CompaniesReiterated RatingSell$4.00View Rating Details
3/14/2016LaidlawLower Price TargetBuy$17.00 -> $11.00View Rating Details
9/18/2015William BlairReiterated RatingBuy$17.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for BioDelivery Sciences International (NASDAQ:BDSI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2017        
11/9/2016Q316($0.26)($0.30)$3.58 million$3.60 millionViewListenView Earnings Details
8/9/2016Q216($0.31)($0.31)$3.35 million$5.00 millionViewN/AView Earnings Details
5/10/2016Q116($0.35)($0.36)$2.96 million$3.00 millionViewListenView Earnings Details
3/10/2016Q415$0.55$0.19$52.40 million$32.20 millionViewListenView Earnings Details
11/9/2015Q315($0.34)($0.39)$1.56 million$1.20 millionViewN/AView Earnings Details
8/10/2015Q215($0.31)($0.37)$3.29 million$1.70 millionViewListenView Earnings Details
5/11/2015Q115($0.20)($0.16)$10.80 million$13.10 millionViewListenView Earnings Details
3/16/2015Q414($0.33)($0.51)$4.00 million$2.50 millionViewN/AView Earnings Details
11/11/2014($0.29)($0.39)ViewN/AView Earnings Details
8/15/2014($0.07)($0.14)ViewN/AView Earnings Details
5/9/2014Q114($0.15)($0.11)$11.60 million$20.69 millionViewN/AView Earnings Details
3/14/2014($0.22)($0.33)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioDelivery Sciences International (NASDAQ:BDSI)
Current Year EPS Consensus Estimate: $-1.23 EPS
Next Year EPS Consensus Estimate: $-0.68 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.40)($0.36)($0.38)
Q2 20162($0.34)($0.34)($0.34)
Q3 20163($0.28)($0.25)($0.26)
Q4 20163($0.30)($0.25)($0.27)
Q1 20173($0.22)($0.18)($0.20)
Q2 20173($0.22)($0.16)($0.19)
Q3 20173($0.19)($0.13)($0.16)
Q4 20173($0.17)($0.11)($0.14)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioDelivery Sciences International (NASDAQ:BDSI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioDelivery Sciences International (NASDAQ:BDSI)
Insider Ownership Percentage: 9.00%
Institutional Ownership Percentage: 53.57%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/30/2017Niraj VasishtInsiderSell6,905$1.91$13,188.55View SEC Filing  
12/1/2016Samuel P. Sears, Jr.DirectorSell12,000$1.67$20,040.00View SEC Filing  
11/23/2016Barry I FeinbergDirectorBuy2,000$1.67$3,340.00View SEC Filing  
11/17/2016Barry I FeinbergDirectorBuy3,000$1.87$5,610.00View SEC Filing  
9/23/2016Francis E Odonnell JrDirectorSell100,000$2.57$257,000.00View SEC Filing  
9/23/2016Niraj VasishtInsiderSell47,000$2.43$114,210.00View SEC Filing  
9/22/2016Paolantonio Ernest Robert DeCFOSell14,800$2.44$36,112.00View SEC Filing  
8/25/2016Barry I FeinbergDirectorBuy2,500$2.55$6,375.00View SEC Filing  
8/11/2016William B StoneDirectorSell16,000$2.57$41,120.00View SEC Filing  
3/21/2016Charles BramlageDirectorBuy8,850$2.82$24,957.00View SEC Filing  
3/18/2016Barry I FeinbergDirectorBuy10,000$2.74$27,400.00View SEC Filing  
3/18/2016Niraj VasishtCTOBuy1,000$2.80$2,800.00View SEC Filing  
3/17/2016Paolantonio Ernest Robert DeCFOBuy4,000$2.60$10,400.00View SEC Filing  
11/24/2015Francis E Odonnell JrDirectorSell50,000$6.01$300,500.00View SEC Filing  
11/13/2015Thomas D'alonzoDirectorBuy4,528$5.52$24,994.56View SEC Filing  
9/3/2015Francis E Odonnell JrDirectorSell20,000$6.43$128,600.00View SEC Filing  
8/26/2015Paolantonio Ernest Robert DeCFOBuy1,650$6.20$10,230.00View SEC Filing  
8/13/2015William B StoneDirectorSell11,500$7.01$80,615.00View SEC Filing  
6/16/2015Francis E Odonnell JrDirectorSell21,597$8.03$173,423.91View SEC Filing  
6/16/2015Mark A SirgoCEOSell4,187$7.97$33,370.39View SEC Filing  
5/26/2015Barry I FeinbergDirectorBuy2,000$7.84$15,680.00View SEC Filing  
5/14/2015Barry I FeinbergDirectorBuy2,000$8.54$17,080.00View SEC Filing  
5/13/2015Thomas D'alonzoDirectorBuy6,226$8.07$50,243.82View SEC Filing  
12/26/2014Francis E Odonnell JrDirectorSell70,000$12.00$840,000.00View SEC Filing  
12/15/2014Mark A SirgoCEOBuy2,500$12.23$30,575.00View SEC Filing  
12/10/2014Samuel P Sears JrDirectorSell7,853$15.03$118,030.59View SEC Filing  
11/12/2014William B StoneDirectorSell14,000$16.11$225,540.00View SEC Filing  
9/4/2014Barry I FeinbergDirectorBuy1,000$15.18$15,180.00View SEC Filing  
9/4/2014Mark A SirgoCEOBuy2,000$15.04$30,080.00View SEC Filing  
8/27/2014Andrew L FinnEVPSell90,000$15.00$1,350,000.00View SEC Filing  
8/22/2014Charles BramlageDirectorBuy1,800$13.85$24,930.00View SEC Filing  
6/25/2014Paolantonio Ernest Robert DeCFOBuy1,250$12.13$15,162.50View SEC Filing  
6/12/2014Samuel P Sears JrDirectorSell5,000$12.33$61,650.00View SEC Filing  
6/11/2014Francis E Odonnell JrDirectorSell125,000$11.04$1,380,000.00View SEC Filing  
3/26/2014Francis Odonnell, Jr.DirectorSell50,000$8.04$402,000.00View SEC Filing  
3/20/2014Samuel Sears, Jr.DirectorSell4,000$9.00$36,000.00View SEC Filing  
3/11/2014Andrew FinnEVPSell80,000$9.99$799,200.00View SEC Filing  
3/11/2014William StoneDirectorSell35,000$10.00$350,000.00View SEC Filing  
2/20/2014Andrew FinnEVPSell18,737$8.84$165,635.08View SEC Filing  
2/20/2014Francis Odonnell, Jr.DirectorSell70,000$8.92$624,400.00View SEC Filing  
2/20/2014Mark SirgoCEOSell42,000$8.92$374,640.00View SEC Filing  
1/24/2014Andrew FinnEVPSell143,679$9.03$1,297,421.37View SEC Filing  
1/24/2014James McnultySVPSell89,223$8.73$778,916.79View SEC Filing  
1/24/2014John SheaDirectorSell130,000$8.78$1,141,400.00View SEC Filing  
1/24/2014Mark SirgoCEOSell116,253$9.01$1,047,439.53View SEC Filing  
11/18/2013Mark SirgoCEOBuy2,337$4.29$10,025.73View SEC Filing  
9/19/2013Francis Odonnell, Jr.DirectorSell95,000$5.36$509,200.00View SEC Filing  
9/11/2013Samuel P Sears JrDirectorSell2,000$5.37$10,740.00View SEC Filing  
9/9/2013Samuel P Sears JrDirectorSell7,500$5.05$37,875.00View SEC Filing  
8/26/2013Andrew FinnEVPBuy5,000$4.58$22,900.00View SEC Filing  
8/16/2013Mark SirgoCEOBuy5,100$4.43$22,593.00View SEC Filing  
8/15/2013William StoneDirectorSell6,825$4.44$30,303.00View SEC Filing  
8/14/2013James McnultyCFOBuy5,000$4.50$22,500.00View SEC Filing  
6/21/2013Mark A SirgoCEOBuy3,400$4.30$14,620.00View SEC Filing  
6/20/2013Francis E Odonnell JrDirectorSell72,689$4.36$316,924.04View SEC Filing  
6/5/2013Samuel P Sears JrDirectorSell5,000$4.42$22,100.00View SEC Filing  
12/21/2012Andrew L FinnEVPBuy3,000$3.85$11,550.00View SEC Filing  
12/21/2012Mark A SirgoCEOBuy4,975$4.02$19,999.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioDelivery Sciences International (NASDAQ:BDSI)
DateHeadline
News IconMoody Stock Sees Increased Volatility Levels in Session: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Aiken Advocate (NASDAQ:BDSI)
aikenadvocate.com - February 22 at 3:56 PM
News IconAnalysts Peer Into Their Crystal Balls For BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Where Is It headed? - Winfield Review (NASDAQ:BDSI)
winfieldreview.com - February 22 at 11:14 AM
News IconWatching Shares of BioDelivery Sciences International, Inc ... - Midway Monitor (NASDAQ:BDSI)
midwaymonitor.com - February 22 at 11:14 AM
News IconConsensus Take: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Earnings & Ratings Watch - Aiken Advocate (NASDAQ:BDSI)
aikenadvocate.com - February 21 at 11:27 AM
News IconConsensus Price Of BioDelivery Sciences International, Inc ... - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - February 20 at 10:14 AM
News IconBrokerage Firm Target Review on BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Rockville Register (NASDAQ:BDSI)
rockvilleregister.com - February 17 at 6:17 PM
News IconEquity Rundown: Checking the Levels for BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - SKV News (NASDAQ:BDSI)
skvnews.com - February 17 at 6:17 PM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Mean Price ... - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - February 17 at 6:17 PM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) EPS Estimate At $-0.05 - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - February 15 at 1:32 AM
realistinvestor.com logoThe Growth Forecast For BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - RealistInvestor.com (NASDAQ:BDSI)
www.realistinvestor.com - February 14 at 8:31 PM
News IconStock Check: Reviewing the Numbers for BioDelivery Sciences International Inc. (BDSI) - Rives Journal (NASDAQ:BDSI)
rivesjournal.com - February 14 at 3:30 PM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Target Price At $5.071 - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - February 13 at 1:55 AM
News IconEPS Target Of BioDelivery Sciences International, Inc. (NASDAQ:BDSI)Set At $-0.05 - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - February 10 at 9:27 PM
seekingalpha.com logoCan BioDelivery Succeed With Belbuca? - Seeking Alpha (NASDAQ:BDSI)
seekingalpha.com - February 10 at 9:27 PM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Price Target Set At $5.071 - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - February 9 at 4:02 PM
News IconNarrowing in on Trading Indicators for BioDelivery Sciences International Inc. (BDSI) - Rives Journal (NASDAQ:BDSI)
rivesjournal.com - February 8 at 2:51 AM
News IconTenax Therapeutics (NASDAQ:TENX)- Stocks Hammered on ... - Street Wise Report (press release) (blog) (NASDAQ:BDSI)
streetwisereport.com - February 6 at 3:53 PM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Price Target At $5.214 - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - February 6 at 3:53 PM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Long-Term Growth Estimate At $25 - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - February 3 at 9:04 PM
News IconInvestor Box: Viewing Levels on Shares of BioDelivery Sciences International Inc. (BDSI) - Sherwood Daily (NASDAQ:BDSI)
sherwooddaily.com - February 1 at 4:05 PM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Projected ... - Stock Observer (NASDAQ:BDSI)
www.thestockobserver.com - February 1 at 4:05 PM
bizjournals.com logoBelbuca return expected to push BDSI to profitability sooner (NASDAQ:BDSI)
www.bizjournals.com - February 1 at 4:05 PM
finance.yahoo.com logoZacks.com featured highlights: D.R. Horton, FleetCor Technologies, MarketAxess Holdings, Maxim Integrated Products and BioDelivery Sciences International (NASDAQ:BDSI)
finance.yahoo.com - January 31 at 4:07 PM
News IconAverage Directional Index Review for BioDelivery Sciences International Inc. (BDSI) - Sherwood Daily (NASDAQ:BDSI)
sherwooddaily.com - January 27 at 10:19 PM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Mean Price Target At $5.357 - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - January 27 at 5:18 PM
News IconStock Watch for BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - The Tribune (NASDAQ:BDSI)
lakecitytribune.com - January 26 at 9:31 PM
News IconTracking Williams %R for BioDelivery Sciences International Inc. (BDSI) - Sherwood Daily (NASDAQ:BDSI)
sherwooddaily.com - January 26 at 4:29 PM
News IconBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Stock ABR At 1.29 - Stock Observer (NASDAQ:BDSI)
www.thestockobserver.com - January 26 at 4:29 PM
News IconEarnings in Full Force, Analysts Take Aim at BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Wall Street Beacon (NASDAQ:BDSI)
wsbeacon.com - January 26 at 4:29 PM
finance.yahoo.com logoBioDelivery Sciences to Hold Analyst and Investor Day to Discuss BELBUCA® Commercialization Plans on February 1st in New York City (NASDAQ:BDSI)
finance.yahoo.com - January 26 at 4:29 PM
News IconTechnical Toolbox: Investor Focus on BioDelivery Sciences International Inc. (BDSI) - Sherwood Daily (NASDAQ:BDSI)
sherwooddaily.com - January 24 at 9:24 PM
bizjournals.com logoResearch Reports Coverage on Biotech Stocks -- Genetic Technologies, Alder Biopharma, BioDelivery Sciences, and Egalet (NASDAQ:BDSI)
www.bizjournals.com - January 24 at 4:24 PM
News IconTarget Price Of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) At $5.357 - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - January 23 at 1:50 AM
News IconMonitoring Relative Strength Index Values for BioDelivery Sciences International Inc. (BDSI) - Sherwood Daily (NASDAQ:BDSI)
sherwooddaily.com - January 20 at 4:53 PM
News IconFocusing on the Charts for BioDelivery Sciences International Inc. (BDSI) - Sherwood Daily (NASDAQ:BDSI)
sherwooddaily.com - January 19 at 4:59 PM
News IconAre Discerning Investors Interested in These Shares: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Prospect Journal (NASDAQ:BDSI)
prospectjournal.com - January 19 at 4:59 PM
News IconStock Momentum Skidding to a Halt For BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Wall Street Beacon (NASDAQ:BDSI)
wsbeacon.com - January 17 at 9:36 PM
News IconPlacing This Stock in the Hotbed: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Prospect Journal (NASDAQ:BDSI)
prospectjournal.com - January 17 at 9:36 PM
nasdaq.com logoIs BioDelivery Sciences (BDSI) a Great Growth Stock? - NASDAQ.com - Nasdaq (NASDAQ:BDSI)
www.nasdaq.com - January 17 at 9:36 PM
finance.yahoo.com logoIs BioDelivery Sciences (BDSI) a Great Growth Stock? (NASDAQ:BDSI)
finance.yahoo.com - January 17 at 9:36 AM
News IconAnalysts Take: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Projected Earnings & Price Targets - Aiken Advocate (NASDAQ:BDSI)
aikenadvocate.com - January 16 at 8:55 PM
News IconReady for an Upsurge? Analysts Chime in on BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Prospect Journal (NASDAQ:BDSI)
prospectjournal.com - January 16 at 8:55 PM
News IconIs the Needle Ready to Move on BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Prospect Journal (NASDAQ:BDSI)
prospectjournal.com - January 16 at 8:55 PM
News IconPrice Target Of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) At $5.357 - Transcript Daily (NASDAQ:BDSI)
transcriptdaily.com - January 14 at 3:50 PM
News IconMarkets End Mostly Higher, How Did This Stock Fare: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Wall Street Beacon (NASDAQ:BDSI)
wsbeacon.com - January 14 at 3:50 PM
reuters.com logoBRIEF-MonoSol Rx files patent infringement suit against Biodelivery Sciences International (NASDAQ:BDSI)
www.reuters.com - January 13 at 4:30 PM
finance.yahoo.com logoMonoSol Rx Files Patent Infringement Suit against BioDelivery Sciences International (BDSI) (NASDAQ:BDSI)
finance.yahoo.com - January 13 at 4:30 PM
investornewswire.com logoSentiments And Ratings Alert: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Investor Newswire (NASDAQ:BDSI)
www.investornewswire.com - January 12 at 9:03 PM
News IconBounding Shares, What's Next for BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Prospect Journal (NASDAQ:BDSI)
prospectjournal.com - January 12 at 4:02 PM
News IconWill The Needle Move For BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:BDSI)
wsbeacon.com - January 12 at 4:02 PM

Social

What is BioDelivery Sciences International's stock symbol?

BioDelivery Sciences International trades on the NASDAQ under the ticker symbol "BDSI."

Where is BioDelivery Sciences International's stock going? Where will BioDelivery Sciences International's stock price be in 2017?

6 brokers have issued 1-year price objectives for BioDelivery Sciences International's shares. Their forecasts range from $3.00 to $11.00. On average, they expect BioDelivery Sciences International's share price to reach $5.50 in the next twelve months.

When will BioDelivery Sciences International announce their earnings?

BioDelivery Sciences International is scheduled to release their next quarterly earnings announcement on Wednesday, March, 8th 2017.

What are analysts saying about BioDelivery Sciences International stock?

Here are some recent quotes from research analysts about BioDelivery Sciences International stock:

  • According to Zacks Investment Research, "BioDelivery expects Bunavail to benefit from the Health and Human Services (HHS) ruling and new contract wins. However, we remain concerned about Bunavail’s performance from the pain market as it discontinued development of clonidine topical gel for management of painful diabetic neuropathy. BioDelivery’s portfolio as well as its pipeline candidates target highly genericized, crowded and competitive markets. Its share price also underperformed Zacks classified Medical-Biomed/Genetics Market in last one year. On the flip side, since this July, the company has secured improved positioning in six new managed care contracts, providing preferred access to Bunavail, which is expected to boost the drug’s sales and profitability in 2017. Estimates have been going down lately ahead of the company’s Q4 earnings release. The company has mixed record of earnings surprises in recent quarters." (2/8/2017)

  • Cantor Fitzgerald analysts commented, "The Pain Strategy: BDSI is currently planning an Investor Day on Feb 1 which will help detail out their market strategy for Belbuca. On a previous conference call, management indicated that the initial strategy would be to focus on MDs who write RXs for and are familiar with buprenorphine, as well as pain management physicians who are high-volume ER opioid writers. Though early in the re-launch, we remain constructive on the share of voice Belbuca will capture given the size of the sales force and where a partial agonist fits into the patient profile of a pain specialist." (1/17/2017)

Who owns BioDelivery Sciences International stock?

BioDelivery Sciences International's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Broadfin Capital LLC (9.98%), Stonepine Capital Management LLC (4.81%), Royce & Associates LP (1.02%), GRT Capital Partners L.L.C. (0.53%), Oxford Asset Management (0.20%) and A.R.T. Advisors LLC (0.18%). Company insiders that own BioDelivery Sciences International stock include Barry I Feinberg, Charles Bramlage, Francis E Odonnell Jr, Mark A Sirgo, Niraj Vasisht, Paolantonio Ernest Robert De, Samuel P Sears, Jr, Thomas D'alonzo and William B Stone.

Who sold BioDelivery Sciences International stock? Who is selling BioDelivery Sciences International stock?

BioDelivery Sciences International's stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP and GRT Capital Partners L.L.C.. Company insiders that have sold BioDelivery Sciences International stock in the last year include Francis E Odonnell Jr, Niraj Vasisht, Paolantonio Ernest Robert De, Samuel P Sears, Jr and William B Stone.

Who bought BioDelivery Sciences International stock? Who is buying BioDelivery Sciences International stock?

BioDelivery Sciences International's stock was purchased by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Broadfin Capital LLC, GSA Capital Partners LLP, Oxford Asset Management and A.R.T. Advisors LLC. Company insiders that have bought BioDelivery Sciences International stock in the last two years include Barry I Feinberg, Charles Bramlage, Niraj Vasisht, Paolantonio Ernest Robert De and Thomas D'alonzo.

How do I buy BioDelivery Sciences International stock?

Shares of BioDelivery Sciences International can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of BioDelivery Sciences International stock cost?

One share of BioDelivery Sciences International stock can currently be purchased for approximately $2.05.

BioDelivery Sciences International (NASDAQ:BDSI) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for BioDelivery Sciences International (NASDAQ:BDSI)

Earnings History Chart

Earnings by Quarter for BioDelivery Sciences International (NASDAQ:BDSI)

Dividend History Chart

Dividend Payments by Quarter for BioDelivery Sciences International (NASDAQ:BDSI)

Last Updated on 2/22/2017 by MarketBeat.com Staff